Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Durivage

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 1, 1986
Adaptation of rat knee meniscus to prolonged exerciseA C Vailas, R F Zernicke, J Matsuda, et al.
Cancer|March 15, 1991
High-dose cisplatin plus dacarbazine in the treatment of metastatic melanomaJ R Murren, W DeRosa, H J Durivage, et al.
Cancer|January 28, 1998
A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervixW P Irvin, F V Price, H Bailey, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase I trial of combined therapy with bleomycin and the calmodulin antagonist, trifluoperazineW N Hait, S Morris, J S Lazo, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Trifluoperazine as a modulator of multidrug resistance in refractory breast cancerJ R Murren, H J Durivage, A C Buzaid, et al.
Cancer Research|October 15, 1990
The effect of calmodulin inhibitors with bleomycin on the treatment of patients with high grade gliomasW N Hait, T N Byrne, J Piepmeier, et al.
Cancer|April 1, 1993
Cyclosporine treatment of refractory T-cell lymphomasD L Cooper, I M Braverman, A H Sarris, et al.
American Journal of Clinical Oncology|April 1, 1992
Phase II study of pulse 5-fluoro-2'-deoxyuridine and leucovorin in advanced colorectal cancer patients previously treated with chemotherapyJ C Marsh, H J Durivage, C Davis, et al.
American Journal of Clinical Oncology|June 1, 1994
Cisplatin, doxorubicin, mitomycin C, and 5-fluorouracil for the treatment of metastatic non-small cell lung cancer. Limited activity of an aggressive chemotherapy regimenJ R Murren, H J Durivage, A H Rosenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancerJ C Marsh, J R Bertino, K H Katz, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 1, 1986
Adaptation of rat knee meniscus to prolonged exerciseA C Vailas, R F Zernicke, J Matsuda, et al.
Cancer|March 15, 1991
High-dose cisplatin plus dacarbazine in the treatment of metastatic melanomaJ R Murren, W DeRosa, H J Durivage, et al.
Cancer|January 28, 1998
A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervixW P Irvin, F V Price, H Bailey, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase I trial of combined therapy with bleomycin and the calmodulin antagonist, trifluoperazineW N Hait, S Morris, J S Lazo, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Trifluoperazine as a modulator of multidrug resistance in refractory breast cancerJ R Murren, H J Durivage, A C Buzaid, et al.
Cancer Research|October 15, 1990
The effect of calmodulin inhibitors with bleomycin on the treatment of patients with high grade gliomasW N Hait, T N Byrne, J Piepmeier, et al.
Cancer|April 1, 1993
Cyclosporine treatment of refractory T-cell lymphomasD L Cooper, I M Braverman, A H Sarris, et al.
American Journal of Clinical Oncology|April 1, 1992
Phase II study of pulse 5-fluoro-2'-deoxyuridine and leucovorin in advanced colorectal cancer patients previously treated with chemotherapyJ C Marsh, H J Durivage, C Davis, et al.
American Journal of Clinical Oncology|June 1, 1994
Cisplatin, doxorubicin, mitomycin C, and 5-fluorouracil for the treatment of metastatic non-small cell lung cancer. Limited activity of an aggressive chemotherapy regimenJ R Murren, H J Durivage, A H Rosenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancerJ C Marsh, J R Bertino, K H Katz, et al.
Pageof 2